Cytokinetics (CYTK) BENEFIT-ALS Update 'Encouraging'; Roth Maintains 'Buy' Rating

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. INTU
2. DKS
3. NVDA
4. META
5. ZM
6. SPY
7. SMTC
8. JAZZ
9. NCNO
10. BOX

Go back to Cytokinetics (CYTK) BENEFIT-ALS Update 'Encouraging'; Roth Maintains 'Buy' Rating
CYTOKINETICS (NASDAQ: CYTK) Delayed: 79.20 +1.74 (2.25%)
Previous Close $77.46    52 Week High $13.18 
Open $77.91    52 Week Low $6.00 
Day High $79.88    P/E N/A 
Day Low $76.70    EPS $-1.24 
Volume 1,236,621